<PAGE>
===============================================================================
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
--------------
SCHEDULE 14D-1
(AMENDMENT NO. 1)
TENDER OFFER STATEMENT
PURSUANT TO SECTION 14(D)(1)
OF THE SECURITIES EXCHANGE ACT OF 1934
--------------
CIRCON CORPORATION
(NAME OF SUBJECT COMPANY)
MMI ACQUISITION CORP.
MAXXIM MEDICAL, INC.
MAXXIM MEDICAL, INC.
(BIDDERS)
COMMON STOCK, PAR VALUE $0.01 PER SHARE
(TITLE OF CLASS OF SECURITIES)
172736 10 0
(CUSIP NUMBER OF CLASS OF SECURITIES)
--------------
KENNETH W. DAVIDSON
PRESIDENT AND CHIEF EXECUTIVE OFFICER
MAXXIM MEDICAL, INC.
10300 49TH STREET NORTH
CLEARWATER, FL 33762
TELEPHONE: (727) 561-2100
FACSIMILE: (727) 561-2170
(NAME, ADDRESS AND TELEPHONE NUMBER OF PERSON AUTHORIZED TO
RECEIVE NOTICES AND COMMUNICATIONS ON BEHALF OF BIDDERS)
COPY TO:
MICHAEL E. GIZANG, ESQ.
SKADDEN, ARPS, SLATE, MEAGHER & FLOM LLP
919 THIRD AVENUE
NEW YORK, NY 10022
TELEPHONE: (212) 735-3000
FACSIMILE: (212) 735-2000
--------------
CALCULATION OF FILING FEE
===============================================================================
TRANSACTION VALUATION* $219,797,445 AMOUNT OF FILING FEE $43,960
===============================================================================
* Estimated for purposes of calculating the amount of the filing fee only.
This amount assumes the purchase of 14,653,163 shares of common stock,
$0.01 par value per share (the "Shares"), of Circon Corporation at a price
of $15.00 per Share in cash, without interest thereon. Such number of
Shares represents the 13,440,490 Shares outstanding as of November 20,
1998, and assumes the issuance prior to the consummation of the Offer of
1,212,673 Shares upon the exercise or conversion of outstanding stock
options and warrants. The amount of the filing fee calculated in
accordance with Regulation 240.0-11 of the Securities Exchange Act of
1934, as amended, equals 1/50th of one percent of the value of the
transaction.
[X] Check box if any part of the fee is offset as provided by Rule 0-11(a)(2)
and identify the filing with which the offsetting fee was previously paid.
Identify the previous filing by registration statement number, or the Form
or Schedule and the date of its filing.
Amount Previously Paid: $43,960
Form or Registration No.: Schedule 14D-1
Filing Party: Maxxim Medical, Inc., Maxxim Medical, Inc. and
MMI Acquisition Corp.
Date Filed: November 30, 1998
===============================================================================
<PAGE>
14D-1
- ---------------------
CUSIP NO. 172736 10 0
- ---------------------
- -------------------------------------------------------------------------------
1 NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS
MMI ACQUISITION CORP.
- -------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ]
(b) [ ]
- -------------------------------------------------------------------------------
3 SEC USE ONLY
- -------------------------------------------------------------------------------
4 SOURCE OF FUNDS
BK
- -------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEM 2(e) OR 2(f) [ ]
- -------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
DELAWARE
- -------------------------------------------------------------------------------
7 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
NONE
- -------------------------------------------------------------------------------
8 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (7) EXCLUDES
CERTAIN SHARES [ ]
- -------------------------------------------------------------------------------
9 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (7)
- -------------------------------------------------------------------------------
10 TYPE OF REPORTING PERSON
CO
- -------------------------------------------------------------------------------
2
<PAGE>
14D-1
- ---------------------
CUSIP NO. 172736 10 1
- ---------------------
- -------------------------------------------------------------------------------
1 NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS
MAXXIM MEDICAL, INC.
- -------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ]
(b) [ ]
- -------------------------------------------------------------------------------
3 SEC USE ONLY
- -------------------------------------------------------------------------------
4 SOURCE OF FUNDS
BK
- -------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEM 2(e) OR 2(f) [ ]
- -------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
DELAWARE
- -------------------------------------------------------------------------------
7 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
NONE
- -------------------------------------------------------------------------------
8 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (7) EXCLUDES
CERTAIN SHARES [ ]
- -------------------------------------------------------------------------------
9 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (7)
- -------------------------------------------------------------------------------
10 TYPE OF REPORTING PERSON
CO
- -------------------------------------------------------------------------------
3
<PAGE>
14D-1
- ---------------------
CUSIP NO. 172736 10 1
- ---------------------
- -------------------------------------------------------------------------------
1 NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS
MAXXIM MEDICAL, INC.
- -------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ]
(b) [ ]
- -------------------------------------------------------------------------------
3 SEC USE ONLY
- -------------------------------------------------------------------------------
4 SOURCE OF FUNDS
BK
- -------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEM 2(e) OR 2(f) [ ]
- -------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
TEXAS
- -------------------------------------------------------------------------------
7 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
NONE
- -------------------------------------------------------------------------------
8. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (7) EXCLUDES
CERTAIN SHARES [ ]
- -------------------------------------------------------------------------------
9 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (7)
- -------------------------------------------------------------------------------
10 TYPE OF REPORTING PERSON
CO
- -------------------------------------------------------------------------------
4
<PAGE>
TENDER OFFER
This Amendment No. 1 amends and supplements the Tender Offer Statement on
Schedule 14D-1 filed on November 30, 1998 (as amended and supplemented, the
"Statement"), relating to the offer by MMI Acquisition Corp., a Delaware
corporation ("Purchaser"), and a wholly owned subsidiary of Maxxim Medical,
Inc., a Delaware corporation ("Parent"), a wholly owned subsidiary of Maxxim
Medical, Inc., a Texas corporation ("Maxxim"), to purchase all of the
outstanding shares of common stock, par value $0.01 per share (the "Common
Stock"), including the associated preferred stock purchase rights issued
pursuant to the Rights Agreement, dated as of August 14, 1996, by and between
the Company and Chase Mellon Shareholder Services, LLC, as Rights Agent (the
"Rights" and, together with the Common Stock, the `Shares"), of Circon
Corporation, a Delaware corporation (the "Company"), at $15.00 per Share, net
to the seller in cash, without interest thereon, upon the terms and subject to
the conditions set forth in the Offer to Purchase, dated November 30, 1998, and
the related Letter of Transmittal. Unless otherwise indicated, the capitalized
terms used herein shall have the meanings specified in the Statement, including
the Offer to Purchase previously filed as Exhibit (a)(1) thereto.
ITEM 10. ADDITIONAL INFORMATION.
On December 10, 1998, Maxxim issued a press release announcing that the
waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976,
as amended, relating to the Offer had expired. The full text of the press
release is attached hereto as Exhibit (a)(10).
ITEM 11. MATERIALS TO BE FILED AS EXHIBITS.
(a)(1) Offer to Purchase, dated November 30, 1998.*
(a)(2) Letter of Transmittal.*
(a)(3) Notice of Guaranteed Delivery.*
(a)(4) Letter to Brokers, Dealers, Commercial Banks, Trust Companies
and Other Nominees.*
(a)(5) Letter to Clients for use by Brokers, Dealers, Commercial Banks,
Trust Companies and Other Nominees.*
(a)(6) Guidelines for Certification of Taxpayer Identification Number
on Substitute Form W-9.*
(a)(7) Press Release, dated November 21, 1998.*
(a)(8) Press Release, dated November 30, 1998.*
(a)(9) Summary Advertisement.*
(a)(10) Press Release, dated December 10, 1998.
(b)(1) Commitment Letter, dated as of November 21, 1998, by and among
Maxxim, NationsBank, N.A. and NationsBanc Montgomery Securities
LLC.*
(c)(1) Agreement and Plan of Merger, dated as of November 21, 1998, by
and among Parent, Purchaser and the Company.*
(c)(2) Exclusivity Agreement, dated as of November 17, 1998, by and
between Maxxim and the Company.*
(d) None.
(e) Not applicable.
(f) None.
- ----------
* Previously filed.
5
<PAGE>
SIGNATURE
After due inquiry and to the best of its knowledge and belief, the
undersigned certifies that the information set forth in this statement is true,
complete and correct.
Dated: December 10, 1998
MMI ACQUISITION CORP.
By: /s/ KENNETH W. DAVIDSON
------------------------------------
Name: Kenneth W. Davidson
Title: President
MAXXIM MEDICAL, INC.
By: /s/ KENNETH W. DAVIDSON
------------------------------------
Name: Kenneth W. Davidson
Title: Chairman of the Board,
President and
Chief Executive Officer
MAXXIM MEDICAL, INC.
By: /s/ KENNETH W. DAVIDSON
------------------------------------
Name: Kenneth W. Davidson
Title: Chairman of the Board,
President and
Chief Executive Officer
<PAGE>
INDEX TO EXHIBITS
<TABLE>
<CAPTION>
SEQUENTIAL
EXHIBIT PAGE NO.
- --------------- -----------
<S> <C> <C>
(a)(1) Offer to Purchase, dated November 30, 1998.*
(a)(2) Letter of Transmittal.*
(a)(3) Notice of Guaranteed Delivery.*
(a)(4) Letter to Brokers, Dealers, Commercial Banks, Trust Companies and Other
Nominees.*
(a)(5) Letter to Clients for use by Brokers, Dealers, Commercial Banks, Trust
Companies and Other Nominees.*
(a)(6) Guidelines for Certification of Taxpayer Identification Number on Substitute
Form W-9.*
(a)(7) Press Release, dated November 21, 1998.*
(a)(8) Press Release, dated November 30, 1998.*
(a)(9) Summary Advertisement.*
(a)(10) Press Release, dated December 10, 1998.
(b)(1) Commitment Letter, dated as of November 21, 1998, by and among Maxxim,
NationsBank, N.A. and NationsBanc Montgomery Securities LLC.*
(c)(1) Agreement and Plan of Merger, dated as of November 21, 1998, by and among
Parent, Purchaser and the Company.*
(c)(2) Exclusivity Agreement, dated as of November 17, 1998, by and between
Maxxim and the Company.*
(d) None.
(e) Not applicable.
(f) None.
</TABLE>
- ----------
* Previously filed.
<PAGE>
Exhibit (a)(10)
FOR: MAXXIM MEDICAL, INC.
APPROVED BY: Peter M. Graham
Executive Vice President
727/561-2100
CONTACTS: Mary Lugris
Investor Relations
727/561-2100
Morgen-Walke Associates
Andrea Kaimowitz/Katherine Mittelbusher
Press: Darren Brandt
212/850-5600
FOR IMMEDIATE RELEASE
MAXXIM MEDICAL ANNOUNCES EXPIRATION OF
HART-SCOTT-RODINO WAITING PERIOD
REGARDING PENDING ACQUISITION OF
CIRCON CORPORATION
CLEARWATER, FLORIDA, DECEMBER 10, 1998 -- MAXXIM MEDICAL, INC. (NYSE: MAM)
announced today that the waiting period under the Hart-Scott-Rodino Antitrust
Improvements Act of 1976, as amended, applicable to the pending acquisition of
Circon Corporation (Nasdaq: CCON) expired at 11:59 p.m., on December 9, 1998.
Maxxim Medical, Inc., its wholly owned subsidiary, MMI Acquisition Corp.
and Circon Corporation executed a merger agreement on November 21, 1998,
pursuant to which MMI Acquisition Corp. commenced on November 30, 1998, a cash
tender offer to purchase all of the outstanding shares of Circon Corporation at
a price of $15.00 per share. The offer is subject to certain conditions,
including among other things, the tender of at least a majority of the shares
of Circon outstanding on a fully diluted basis. The offer and withdrawal rights
are scheduled to expire at 5:00 p.m., New York City time, on Tuesday, January
5, 1999, unless the offer is extended.
Maxxim Medical is a major, diversified manufacturer, distributor and
marketer of disposable specialty medical products such as custom procedure
trays, medical gloves, electrosurgical systems and disposable products for use
in cardiology, radiology and critical care. Maxxim has annual revenues in
excess of $500 million.
This press release is neither an offer to purchase nor a solicitation of
an offer to sell securities. The tender offer is made only through the Offer to
Purchase and the related Letter of Transmittal which were distributed on or
about November 30, 1998 to stockholders. Additional copies of such documents
can be obtained by contacting, MacKenzie Partners, Inc., the Information Agent,
at (212) 929-5500 (collect) or call toll free at (800) 322-2885.
###
